Addex Therapeutics Ltd

NASDAQ: ADXN · Real-Time Price · USD
8.00
0.48 (6.38%)
At close: Aug 15, 2025, 3:47 PM
7.94
-0.75%
After-hours: Aug 15, 2025, 04:00 PM EDT

Addex Therapeutics Ltd Balance Sheet Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.34M 3.87M 6.96M 20.48M
Short-Term Investments
6.5K 848.00 3.17K 17.14K
Long-Term Investments
7.09M n/a n/a n/a
Other Long-Term Assets
7.09K 54.34K 54.35K 57.91K
Receivables
15.51K 151.27K 598.32K 324.42K
Inventory
n/a n/a -871.6M n/a
Other Current Assets
7.97K n/a n/a n/a
Total Current Assets
3.54M 4.23M 7.83M 21.94M
Property-Plant & Equipment
42.71K 352.94K 398.73K 542.1K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
7.14M 407.28K 453.09K 600.01K
Total Assets
10.68M 4.64M 8.28M 22.54M
Account Payables
253.29K 984.38K 1.28M 1.79M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
n/a 234.98K n/a n/a
Total Current Liabilities
802.09K 2.89M 3.28M 4.13M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
164.25K 532.76K n/a 1.28M
Total Long-Term Liabilities
198.94K 603.14K 87.03K 1.48M
Total Liabilities
1M 3.5M 3.37M 5.61M
Total Debt
41.99K 344.34K 373.13K 482.01K
Common Stock
1.84M 1.84M 1.15M 49.27M
Retained Earnings
-353.36M -360.42M -349.86M -329.06M
Comprehensive Income
31.06M 29.81M 25.77M 24.44M
Shareholders Equity
9.68M 1.15M 4.91M 16.93M
Total Investments
7.09M 848.00 3.17K 17.14K